A 90-year-old woman living in a nursing home with diabetes mellitus, hypertension dependent, hypothyroidism and severe neurodegeneration (Alzheimer's disease).
At the beginning of 2020, COVID-19 was suspected from a clinical picture of CRT with nasopharyngeal PCR-CRC, atrial fibrillation and fever, and confirmed on April 5 with a positive SA-2 test.
She was hospitalized in a COVID-19 ICU.
A chest CT scan revealed signs of bilateral pleural effusion, with no typical signs of pulmonary infection due to SARS-CoV-2.
The patient received several doses of preventive anticoagulants (risk ratio did not favor therapeutic anticoagulant treatment), diuretics and antibiotics (ofloxacin), as well as 5 days of prednisolone at 40 mg/day.
A clinical improvement was observed and the patient was transferred to a rehabilitation unit of COVID-19 on April 21, before being able to return to his residence on May 7.
The patient continued to present inflammatory syndrome with stable C-reactive protein at 55 in conditions of chronic pressure ulcers.
The second hospitalization in an acute ICU of COVID-19 May 11, was caused by the appearance of a severe oxygen saturation, with hypernatremia measured at 166 mmol/L, honey deterioration of 93% with four characteristics.
The analyses revealed a clear‚ñÅlymphocytic 0,18 Giga/L and C-reactive protein at 181 ng/L.
The SARS-CoV-2 test by RT-PCR was positive from a nasopharyngeal swab (Ct of 18.8) on May 6.
On May 14, after worsening of the respiratory status, a chest CT scan revealed pulmonary condensation and a bilateral diffuse empedal pattern that affected approximately 25 to 50% of the lung parenchyma, with bilateral proximal lobular pulmonary embolism.
No serological test was performed.
After discussion with the family and interdisciplinary validation, it was decided to apply palliative care.
The patient died on May 19th.
